Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Fox Chase’s Richard E. Greenberg Receives American Urologic Association’s Residents Committee Teaching Award
PHILADELPHIA (March 24, 2016) — Richard E. Greenberg, MD, FACS, chief of urologic oncology at Fox Chase Cancer Center, will receive the 2016 American Urologic Association (AUA)’s Residents Committee Teaching Award at the organization’s annual meeting in San Diego this May.
The AUA Residents Committee Teaching Award is presented annually to an outstanding urology educator or program director who has dedicated a portion of his/her career to teaching residents. This award also recognizes an individual who influences residents to pursue a career in academic medicine.
“After obtaining knowledge, the next best thing is to pass it on,” said Greenberg. “I am honored to receive this award. The residents I work with are some of the hardest working people I know and I look forward to strengthening the urology program at Fox Chase with them.” Greenberg will be recognized at the Residents Forum on Saturday, May 7.
Greenberg began his career at Fox Chase in 1983. He specializes in the treatment of kidney, prostate, penile, testicular, ureteral, urethral and bladder cancers, as well as the treatment of adrenal masses. He is skilled in minimally invasive procedures, including pure robotic surgery.
Greenberg is certified by the AUA Board of Urology. He received his MD from Cornell University Medical School and completed residencies at New York-Presbyterian Hospital and Memorial Sloan-Kettering Cancer Center.
The AUA Annual Meeting is the largest gathering of urologists in the world, providing unparalleled access to groundbreaking research, new guidelines and the latest advances in urologic medicine.
To find out more about this year’s annual meeting and award winners, visit http://www.aua2016.org/.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427